Safety of Same-Day Discharge After Elective Transcatheter Aortic Valve Implantation With Balloon- and Self-Expanding Valves: A Prospective Single-Center UK Study
Structural Heart · 2025-11 · 9 (11) · 100728
DOI: 10.1016/j.shj.2025.100728 ↗Kurz gefasst
Fachartikel in der Zeitschrift Structural Heart, 2025-11. Verfasst von Saif Memon und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardiothoracic Centre, Freeman Hospital, Newcastle-upon-Tyne, UK. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In patients undergoing transcatheter aortic valve implantation (TAVI), it is unclear whether same-day discharge (SDD) while adopting a device-agnostic approach is a safe strategy compared to non-SDD. We aim to compare TAVI patients who underwent SDD and non-SDD according to a predefined protocol.
Methods
This is a prospective single-center study of consecutive patients who were scheduled for elective TAVI procedures. The primary endpoint was the composite of death, vascular access-related complications, any bleeding requiring hospitalization, all stroke (or transient ischemic attack), or new permanent pacemaker implantation at 30 days defined according to the Valve Academic Research Consortium 3 criteria.
Results
Out of 472 consecutive patients who underwent elective TAVI, 289 patients did not report procedural complications, of whom 60 (21%) were discharged on the same day. The mean age was 81 ± 7 years, with 60% of the cohort being male. There were no significant differences in clinical characteristics among patients according to their in-hospital SDD strategy. Pre-existing left or right bundle branch block was comparable between the 2 groups. The primary endpoint was reported in 2.8% of the entire cohort, with no significant difference between patients who underwent SDD TAVI and those who did not (1.7% vs. 3.1%, respectively, p = 0.56). Patients who had a self-expanding valve had a comparable primary endpoint to those who had a balloon-expandable valve, including readmission for a permanent pacemaker.
Conclusions
SDD TAVI is a safe and feasible approach in patients who underwent an elective uneventful procedure, including patients who received self-expanding valves. Future studies are required to support these findings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiothoracic Centre, Freeman Hospital, Newcastle-upon-Tyne, UK.
- Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, UK.
Zitieren
APA
Memon, S., Omari, M., Stewart, D., Chong, H. H., Ali, M., Edwards, R., Das, R., Cartlidge, T., Zaman, A., Farag, M., & Alkhalil, M. (2025). Safety of Same-Day Discharge After Elective Transcatheter Aortic Valve Implantation With Balloon- and Self-Expanding Valves: A Prospective Single-Center UK Study. Structural Heart, 9(11), 100728. https://doi.org/10.1016/j.shj.2025.100728
Vancouver
Memon S, Omari M, Stewart D, Chong HH, Ali M, Edwards R, et al. Safety of Same-Day Discharge After Elective Transcatheter Aortic Valve Implantation With Balloon- and Self-Expanding Valves: A Prospective Single-Center UK Study. Structural Heart. 2025;9(11):100728. doi:10.1016/j.shj.2025.100728
BibTeX
@article{Memon2025,
author = {Memon, Saif and Omari, Muntaser and Stewart, Debbie and Chong, Hong Hong and Ali, Mohamed and Edwards, Richard and Das, Rajiv and Cartlidge, Tim and Zaman, Azfar and Farag, Mohamed and Alkhalil, Mohammad},
title = {Safety of Same-Day Discharge After Elective Transcatheter Aortic Valve Implantation With Balloon- and Self-Expanding Valves: A Prospective Single-Center UK Study},
journal = {Structural Heart},
year = {2025},
volume = {9},
number = {11},
pages = {100728},
doi = {10.1016/j.shj.2025.100728}
}
EUVIMED